Tempest Therapeutics (TPST) EBITDA (2012 - 2026)
Tempest Therapeutics (TPST) recorded EBITDA of -$5.19 million in Q2 2026, compared with -$7.9 million a year earlier.
Powered by 
Analysis
Tempest Therapeutics (TPST) EBITDA (2012 - 2026) Analysis & Trends
On a TTM basis, Tempest Therapeutics' EBITDA came in at -$20.63 million as of Jun 30, 2026; for FY2025, it was -$26.31 million.
- Across earlier years, EBITDA came in at -$41.64 million in FY2024, -$28.78 million in FY2023, -$34 million in FY2022 and -$26.61 million in FY2021.
- Quarterly EBITDA has ranged from -$13.87 million in Q4 2024 to -$3.53 million in Q3 2025 over the past five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Tempest Therapeutics | 8.31 Mn | -22.01 Mn | - | -5.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5.19 Mn |
| Dec 31, 2025 | -4.01 Mn |
| Sep 30, 2025 | -3.53 Mn |
| Jun 30, 2025 | -7.90 Mn |
| Mar 31, 2025 | -10.87 Mn |
| Dec 31, 2024 | -13.87 Mn |
| Sep 30, 2024 | -10.45 Mn |
| Jun 30, 2024 | -9.43 Mn |
| Mar 31, 2024 | -7.89 Mn |
| Dec 31, 2023 | -7.43 Mn |
| Sep 30, 2023 | -6.50 Mn |
| Jun 30, 2023 | -7.39 Mn |
| Mar 31, 2023 | -7.46 Mn |
| Dec 31, 2022 | -8.72 Mn |
| Sep 30, 2022 | -8.57 Mn |
| Jun 30, 2022 | -8.66 Mn |
| Mar 31, 2022 | -8.05 Mn |
| Dec 31, 2021 | -7.24 Mn |
| Sep 30, 2021 | -7.63 Mn |
| Jun 30, 2021 | -6.70 Mn |
API Access
Tempest Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=TPST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "TPST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=TPST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();